| Product Name | Troxacitabine (Synonyms: BCH 4556; L-OddC; SPD 758) | 
|---|---|
| CAS | 145918-75-8 | 
| Formula | C8H11N3O4 | 
| MW | 213.19 | 
| MDL | MFCD00871100 | 
| Appearance | White to off-white powder | 
| Storage condition | 4°C, protect from light | 
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity | 
|---|---|---|---|---|
| 2 mg | 3-5 days | ¥1366.00 | Visible after login | |
| 5 mg | 3-5 days | ¥2636.00 | Visible after login | |
| 10 mg | 3-5 days | ¥4366.00 | Visible after login | 
| Product Name | Troxacitabine (Synonyms: BCH 4556; L-OddC; SPD 758) | 
|---|---|
| CAS | 145918-75-8 | 
| Formula | C8H11N3O4 | 
| MW | 213.19 | 
| MDL | MFCD00871100 | 
| Appearance | White to off-white powder | 
| Storage condition | 4°C, protect from light | 
Troxacitabine, a DNA polymerase inhibitor, shows potential in treating acute myeloid leukemia (AML) and has demonstrated activity against pancreatic cancer cell lines MiaPaCa and Panc-01, with greater efficacy against Panc-01. As a nucleoside analog, it possesses significant anticancer properties.
PMID: 10778991
Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts
PMID: 12451476 DOI: 10.1007/s00280-002-0530-7